Gui Y - Search Results

1

The MNK1/2-eIF4E Axis Supports Immune Suppression and Metastasis in Postpartum Breast Cancer.

Guo Q, Bartish M, Gonçalves C, Huang F, Smith-Voudouris J, Krisna SS, Preston SEJ, Emond A, Li VZ, Duerr CU, Gui Y, Cleret-Buhot A, Thebault P, Lefrère H, Lenaerts L, Plourde D, Su J, Mindt BC, Hewgill SA, Cotechini T, Hindmarch CCT, Yang W, Khoury E, Zhan Y, Narykina V, Wei Y, Floris G, Basik M, Amant F, Quail DF, Lapointe R, Fritz JH, Del Rincon SV, Miller WH Jr. Guo Q, et al. Among authors: gui y. Cancer Res. 2021 Jul 15;81(14):3876-3889. doi: 10.1158/0008-5472.CAN-20-3143. Epub 2021 May 11. Cancer Res. 2021. PMID: 33975880

2

Metastatic Breast Carcinoma-Associated Fibroblasts Have Enhanced Protumorigenic Properties Related to Increased IGF2 Expression.

Gui Y, Aguilar-Mahecha A, Krzemien U, Hosein A, Buchanan M, Lafleur J, Pollak M, Ferrario C, Basik M. Gui Y, et al. Clin Cancer Res. 2019 Dec 1;25(23):7229-7242. doi: 10.1158/1078-0432.CCR-19-1268. Epub 2019 Sep 12. Clin Cancer Res. 2019. PMID: 31515454

3

Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.

Gui Y, Khan MGM, Bobbala D, Dubois C, Ramanathan S, Saucier C, Ilangumaran S. Gui Y, et al. World J Gastroenterol. 2017 Sep 28;23(36):6639-6649. doi: 10.3748/wjg.v23.i36.6639. World J Gastroenterol. 2017. PMID: 29085209 Free PMC article.

4

SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity.

Ilangumaran S, Gui Y, Shukla A, Ramanathan S. Ilangumaran S, et al. Among authors: gui y. Front Immunol. 2024 Feb 13;15:1362224. doi: 10.3389/fimmu.2024.1362224. eCollection 2024. Front Immunol. 2024. PMID: 38415248 Free PMC article.

5

SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes.

Gui Y, Yeganeh M, Ramanathan S, Leblanc C, Pomerleau V, Ferbeyre G, Saucier C, Ilangumaran S. Gui Y, et al. J Hepatol. 2011 Dec;55(6):1300-8. doi: 10.1016/j.jhep.2011.03.027. Epub 2011 May 19. J Hepatol. 2011. PMID: 21703184

6

Regulation of MET receptor signaling by SOCS1 and its implications for hepatocellular carcinoma.

Gui Y, Yeganeh M, Cepero-Donates Y, Ramanathan S, Saucier C, Ilangumaran S. Gui Y, et al. Curr Pharm Des. 2014;20(17):2922-33. doi: 10.2174/13816128113199990597. Curr Pharm Des. 2014. PMID: 23944359 Review.

7

Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.

Yeganeh M, Gui Y, Kandhi R, Bobbala D, Tobelaim WS, Saucier C, Yoshimura A, Ferbeyre G, Ramanathan S, Ilangumaran S. Yeganeh M, et al. Among authors: gui y. Oncogene. 2016 Aug 11;35(32):4200-11. doi: 10.1038/onc.2015.485. Epub 2016 Jan 4. Oncogene. 2016. PMID: 26725321

8

Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.

Gui Y, Yeganeh M, Donates YC, Tobelaim WS, Chababi W, Mayhue M, Yoshimura A, Ramanathan S, Saucier C, Ilangumaran S. Gui Y, et al. Oncogene. 2015 Nov 12;34(46):5718-28. doi: 10.1038/onc.2015.20. Epub 2015 Mar 2. Oncogene. 2015. PMID: 25728680

9

Multi-functional adaptor SKAP1: regulator of integrin activation, the stop-signal, and the proliferation of T cells.

Liu C, Raab M, Gui Y, Rudd CE. Liu C, et al. Among authors: gui y. Front Immunol. 2023 May 31;14:1192838. doi: 10.3389/fimmu.2023.1192838. eCollection 2023. Front Immunol. 2023. PMID: 37325633 Free PMC article. Review.

10

Regulation of Hedgehog signaling by ubiquitination.

Hsia EY, Gui Y, Zheng X. Hsia EY, et al. Among authors: gui y. Front Biol (Beijing). 2015 Jun;10(3):203-220. doi: 10.1007/s11515-015-1343-5. Front Biol (Beijing). 2015. PMID: 26366162 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,328 results

Search Page

Filters